# A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

> **NCT00816764** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 18 (actual)

## Conditions studied

- Carcinoma
- Ovarian Cancer
- Ovarian Diseases
- Ovarian Neoplasms

## Interventions

- **BIOLOGICAL:** AGS-8M4

## Key facts

- **NCT ID:** NCT00816764
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816764, "A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00816764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*